Economic Evaluation of Tobacco Treatments From the Screen ASSIST Lung Cancer Screening Trial

Of the 8 smoking cessation strategies used in the Screen ASSIST trial among patients undergoing lung cancer screening, which was most cost-effective?This economic evaluation study including 642 participants found that 8 sessions of telehealth counseling combined with 2 weeks of nicotine replacement therapy was the most cost-effective intervention, with an incremental cost per quit of $3050. Sensitivity analyses illustrate potential cost differences in alternative settings.These findings suggest that health systems can use this favorable incremental cost per quit and transparent cost estimation to promote wider implementation of the intervention.

Corresponding Author: Douglas E. Levy, PhD, Mongan Institute Health Policy Research Center, Massachusetts General Hospital, 100 Cambridge St, Ste 1600, Boston, MA 02114 (dlevy3@mgh.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.